| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
-0.0027 |
0.9 |
| mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.004 |
0.9 |